UK markets closed

Akoya Biosciences, Inc. (AKYA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.0400+0.0500 (+1.25%)
At close: 04:00PM EDT
4.0400 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-63,323
-63,323
-70,641
-42,935
-16,706
Depreciation & amortisation
8,890
8,890
7,149
4,792
3,815
Deferred income taxes
-51
-51
35
-155
7
Stock-based compensation
10,437
10,437
7,430
4,039
477
Change in working capital
-14,478
-14,478
153
-4,561
2,394
Accounts receivable
-7,265
-7,265
-285
-2,974
6,697
Inventory
-6,332
-6,332
-5,374
-4,628
-684
Accounts payable
1,148
1,148
1,193
4,361
-3,045
Other working capital
-54,552
-54,552
-60,856
-41,162
-10,138
Other non-cash items
7,631
7,631
2,517
2,500
1,201
Net cash provided by operating activities
-50,899
-50,899
-53,496
-36,068
-6,843
Cash flows from investing activities
Investments in property, plant and equipment
-3,653
-3,653
-7,360
-5,094
-3,295
Purchases of investments
0
0
-40,774
0
0
Sales/maturities of investments
7,000
7,000
34,000
0
10,168
Net cash used for investing activities
3,347
3,347
-14,079
-5,094
6,728
Cash flows from financing activities
Debt repayment
-676
-676
-621
-322
-25,191
Common stock issued
47,967
47,967
0
138,553
0
Other financing activities
-2,043
-2,043
-2,350
-1,590
-4,421
Net cash used provided by (used for) financing activities
56,844
56,844
28,726
137,035
5,486
Net change in cash
9,292
9,292
-38,849
95,873
5,371
Cash at beginning of period
74,532
74,532
113,381
17,508
12,137
Cash at end of period
83,824
83,824
74,532
113,381
17,508
Free cash flow
Operating cash flow
-50,899
-50,899
-53,496
-36,068
-6,843
Capital expenditure
-3,653
-3,653
-7,360
-5,094
-3,295
Free cash flow
-54,552
-54,552
-60,856
-41,162
-10,138